BTNL2 gene polymorphism and sarcoid uveitis.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
12 2019
Historique:
received: 30 07 2018
revised: 16 01 2019
accepted: 20 02 2019
pubmed: 16 3 2019
medline: 30 5 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

Uveitis is a frequent and early feature of sarcoidosis. As BTNL2 (butyrophilin-like 2) gene polymorphism was found linked with the susceptibility to sarcoidosis, we investigated whether a specific genotype of BTNL2 gene G16071A (or rs2076530) single-nucleotide polymorphism (SNP) would be associated with the risk of sarcoid uveitis in all patient subgroups. The study compared the genotype frequencies of SNP G16071A of 135 patients with sarcoid uveitis (Sa A statistically significant difference in genotype frequencies was found between the groups Sa No association was found between G16071A and the susceptibility to sarcoid uveitis. BTNL2 gene G16071A SNP seems to be a predisposing factor for sarcoidosis except in Caucasian postmenopausal women with sarcoid uveitis in whom the GG genotype prevails. These and future results will help in understanding differences between particular subgroups of patients with sarcoid uveitis.

Sections du résumé

BACKGROUND
Uveitis is a frequent and early feature of sarcoidosis. As BTNL2 (butyrophilin-like 2) gene polymorphism was found linked with the susceptibility to sarcoidosis, we investigated whether a specific genotype of BTNL2 gene G16071A (or rs2076530) single-nucleotide polymorphism (SNP) would be associated with the risk of sarcoid uveitis in all patient subgroups.
METHODS
The study compared the genotype frequencies of SNP G16071A of 135 patients with sarcoid uveitis (Sa
RESULTS
A statistically significant difference in genotype frequencies was found between the groups Sa
CONCLUSION
No association was found between G16071A and the susceptibility to sarcoid uveitis. BTNL2 gene G16071A SNP seems to be a predisposing factor for sarcoidosis except in Caucasian postmenopausal women with sarcoid uveitis in whom the GG genotype prevails. These and future results will help in understanding differences between particular subgroups of patients with sarcoid uveitis.

Identifiants

pubmed: 30872286
pii: bjophthalmol-2018-312949
doi: 10.1136/bjophthalmol-2018-312949
doi:

Substances chimiques

BTNL2 protein, human 0
Butyrophilins 0
DNA Primers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1690-1694

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Mayeul Chaperon (M)

Internal Medicine, Hopital de la Croix-Rousse, Lyon, France.

Yves Pacheco (Y)

Pneumology, Centre Hospitalier Universitaire de Lyon, Lyon, France.

Delphine Maucort-Boulch (D)

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France.
UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, CNRS, Lyon, France.

Jean Iwaz (J)

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France.
UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, CNRS, Lyon, France.

Laurent Perard (L)

Internal Medicine, Centre Hospitalier Saint Joseph Saint Luc, Lyon, France.

Christiane Broussolle (C)

Internal Medicine, Hopital de la Croix-Rousse, Lyon, France.

Yvan Jamilloux (Y)

Internal Medicine, Hopital de la Croix-Rousse, Lyon, France.

Carole Burillon (C)

Department of Ophthalmology, HEH, Hospices Civils de Lyon, Lyon, France.

Laurent Kodjikian (L)

Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.

Alain Calender (A)

Molecular Genetics, Centre Hospitalier Universitaire de Lyon, Lyon, France.

Pascal Seve (P)

Internal Medicine, University Claude Bernard, Lyon, France pascal.seve@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH